Exicure (XCUR) Accumulated Expenses (2016 - 2026)
Exicure (XCUR) reported Accumulated Expenses of $2.0 million for Q1 2026, down 24.79% on a YoY basis from $2.7 million in Q1 2025, and down 8.33% quarter-over-quarter from $2.2 million in Q4 2025.
Exicure (XCUR) Accumulated Expenses (2016 - 2026) Analysis & Trends
Exicure has reported Accumulated Expenses for 11 years, with the latest figure at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses fell 24.79% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 24.79% YoY), and the FY2025 full-year result was $2.2 million, up 7.75% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $2.0 million, down from $2.2 million in the prior quarter.
- The five-year high for Accumulated Expenses was $3.3 million in Q2 2022, with the low at $836000.0 in Q1 2024.
- Historically, Accumulated Expenses has averaged $1.9 million across 5 years, with a median of $2.0 million in 2026.
- Annual changes were most pronounced in 2022 — Accumulated Expenses plunged 80.23% — and 2025, when it jumped 222.81%.
- Exicure's Accumulated Expenses stood at $1.3 million in 2022, then plunged by 31.22% to $879000.0 in 2023, then soared by 132.08% to $2.0 million in 2024, then advanced by 7.75% to $2.2 million in 2025, then decreased by 8.33% to $2.0 million in 2026.
- The last three Accumulated Expenses figures came in at $2.0 million (Q1 2026), $2.2 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.02 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Mar 31, 2025 | 2.68 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 2.32 Mn |
| Jun 30, 2024 | 846,000.00 |
| Mar 31, 2024 | 836,000.00 |
| Dec 31, 2023 | 879,000.00 |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 3.02 Mn |
| Jun 30, 2022 | 3.31 Mn |
| Mar 31, 2022 | 3.23 Mn |
| Dec 31, 2021 | 6.46 Mn |
| Sep 30, 2021 | 5.48 Mn |
| Jun 30, 2021 | 3.23 Mn |